Amwell Expands Leadership Team with Appointment of Dr. Carrie Nelson as Chief Medical Officer

Innovative physician leader brings more than two decades experience to Amwell clinical, go to market and customer success initiatives

June 8, 2022 – Amwell® (NYSE: AMWL), a digital care delivery leader, has named Dr. Carrie Nelson as its new Chief Medical Officer. In this role, Dr. Nelson will focus on empowering provider and payer organizations as they seek to achieve greater clinical, operational, and financial outcomes through digital care delivery powered by Converge™, Amwell’s enterprise-grade infrastructure software platform. Dr. Nelson will also be responsible for leading clients in their improvement of population health in today’s new era of hybrid healthcare and will have clinical oversight of healthcare professionals practicing on behalf of Amwell clinical partner, the Amwell Medical Group.

“We are honored to welcome Carrie to our executive team. Her experience as a physician and her impressive background in value-based care and focus on driving health outcomes and risk management for large provider organizations, make her the right person to extend our clinical vision,” said Kurt Knight, Chief Operating Officer, Amwell. “Carrie’s clinical perspective will be crucial to the continued sales and implementation of our infrastructure software, which provides the engine to connect and empower healthcare organizations as they pursue their digital care delivery aspirations. Carrie will help our customers define new standards of care, drive important quality metrics, and achieve efficiencies, while enhancing patient and provider experiences across the care continuum.”

Dr. Nelson joins Amwell from Advocate Aurora Health where she most recently served as Senior Vice President and CMO for Population Health and Health Outcomes. She also served as the Chief Clinical Officer for Advocate Physician Partners, a benchmark organization known internationally for delivering value-based care in collaboration with about 5000 employed and independent physician practices. With more than 28 years’ experience as a Family Medicine provider, Dr. Nelson is an innovative physician leader with a proven track record in the fields of quality improvement, patient safety and population health. Having served on the board and as president of the Illinois Academy of Family Physicians, she has been a leader at the national level, has chaired the American Academy of Family Physicians Commission on Science and Health of the Public, and has regularly engaged in influencing healthcare policy.

“As a physician, I am passionate about improving patient care and have a deep understanding of the unique challenges that care teams face every day. These challenges have only worsened following the pandemic, and I believe that technology has the power to improve outcomes and address the retention and burnout crisis currently facing our healthcare system,” said Dr. Nelson. “I am excited to have the opportunity to help deliver on Amwell’s vision for empowering digital care delivery, as we work to enable an integrated experience across a full spectrum of physical, virtual and automated care – and make it easier for healthcare organizations to achieve their digital care delivery goals.”

About Amwell
Amwell is a leading digital care delivery platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers digital health solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives. For more information, please visit

American Well, Amwell, SilverCloud, Conversa, Converge and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at and on the SEC’s website at

SOURCE: Amwell